Biomarker testing helps many patients facing serious diseases get the right treatment at the right time. When it comes to cancer, this testing often allows doctors to precisely target a specific ...
On Tuesday, Anixa Biosciences, Inc. (NASDAQ:ANIX) entered into a letter of intent with VERDI Solutions GmbH to develop personalized and off-the-shelf peptide vaccines for cancer patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback